Clinical Trial Update: LMB-9 Immunotoxin in Treating Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial update on LMB-9 immunotoxin in patients with advanced solid tumors. The study has completed and includes bladder cancer, breast cancer, colorectal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Breast Cancer
• Colorectal Cancer
• Esophageal Cancer
• Gastric Cancer
• Lung Cancer
• Pancreatic Cancer

Drugs mentioned

• LMB-9 immunotoxin

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Bladder Cancer, Breast Cancer | Phase 1 | Status: COMPLETED